Moderna Newsroom

Moderna Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones24minutes ago

Moderna Analyst Ratings

Benzinga34minutes ago

Major rating｜Morgan Stanley: Downgrades Moderna's Target Price to $38, maintains a "Neutral" rating.

Gelonghui Finance22:01

Morgan Stanley Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $38

Futu News19:33

J.P. Morgan Downgrades Moderna(MRNA.US) to Sell Rating

Futu NewsJan 14 22:31

BofA Securities Maintains Moderna(MRNA.US) With Sell Rating, Maintains Target Price $41

Futu NewsJan 14 05:31

Bernstein Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $55

Futu NewsJan 12 00:31

UBS Group has lowered the Target Price for Moderna to 96 dollars.

Gelonghui FinanceJan 9 17:40

Moderna Analyst Ratings

BenzingaJan 8 23:05

Bernstein Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $55

Futu NewsJan 8 20:38

UBS Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $96

Futu NewsJan 8 20:34

Argus Research Downgrades Moderna(MRNA.US) to Hold Rating

Futu NewsDec 19, 2024 01:31

Moderna Analyst Ratings

BenzingaDec 19, 2024 00:16

Argus Research Downgrades Moderna(MRNA.US) to Hold Rating

Futu NewsDec 18, 2024 20:32

BofA Securities Initiates Moderna(MRNA.US) With Sell Rating, Announces Target Price $41

Futu NewsDec 11, 2024 16:31

Moderna Analyst Ratings

BenzingaDec 10, 2024 20:31

B of A Securities Reinstates Underperform on Moderna, Announces $41 Price Target

BenzingaDec 10, 2024 20:31

Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $69

Futu NewsDec 6, 2024 20:33

Moderna Analyst Ratings

BenzingaNov 26, 2024 22:42

JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating

MT NewswiresNov 26, 2024 18:35